AI Summary & Key Takeaways
AI InsightA repeatedthrombolytic treatment could be an alternative treatment for these patients, considering treatment’s risks.
📌 3 Key Takeaways
Özet
We present 2 cases of pulmonary thromboembolism (PTE). The first case, a 50-year-old man, was admitted to the emergency departmentbecause of sudden onset dyspnea and left side chest pain. He was diagnosed with intermediate-risk (submassive) PTE, and thrombolytic treatment was commenced. The patient fully recovered, but 5 days later, he was diagnosed with a new, high-risk PTE. The secondpatient, a 23-year-old woman, presented with syncope, dyspnea, and chest pain for 2 days. She was diagnosed with high-risk (massive)PTE. Thrombolytic treatment was commenced, and the patient fully recovered, too. But the later patient was also diagnosed with a newPTE 4 days later. We applied repeated thrombolytic treatment in the patients due to repeated PTE. The first patient fully recovered andwas discharged from the hospital, but the second patient died because of gastrointestinal bleeding and renal insufficiency. A repeatedthrombolytic treatment could be an alternative treatment for these patients, considering treatment’s risks.